An E2F7/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteria

MLA

Lincheng Zhang, et al. “An E2F7/TSC1-Based Model for Predicting the Efficacy of Sirolimus after Liver Transplantation for Hepatocellular Carcinoma beyond the Milan Criteria.” Chinese Medical Journal, vol. 137, no. 16, Aug. 2024, pp. 1973–75. EBSCOhost, https://doi.org/10.1097/CM9.0000000000003102.

APA

Lincheng Zhang, Wei Zhou, Shusen Zheng, Sunbin Ling, Xiao Xu, & Jing Ni. (2024). An E2F7/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Chinese Medical Journal, 137(16), 1973–1975. https://doi.org/10.1097/CM9.0000000000003102

Chicago

Lincheng Zhang, Wei Zhou, Shusen Zheng, Sunbin Ling, Xiao Xu, and Jing Ni. 2024. “An E2F7/TSC1-Based Model for Predicting the Efficacy of Sirolimus after Liver Transplantation for Hepatocellular Carcinoma beyond the Milan Criteria.” Chinese Medical Journal 137 (16): 1973–75. doi:10.1097/CM9.0000000000003102.